Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT (MEMMAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01356290
Recruitment Status : Recruiting
First Posted : May 19, 2011
Last Update Posted : August 20, 2020
Sponsor:
Information provided by (Responsible Party):
Andreas Peyrl, Medical University of Vienna

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2021
Estimated Study Completion Date : April 2023